Violation Tracker Parent Company Summary
Parent Company Name:
Pfizer
Ownership Structure:
publicly traded (ticker symbol PFE)
Headquartered in:
New York
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
Penalty total since 2000:
$4,660,896,333
Number of records:
71
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
|---|---|---|
| healthcare-related offenses | $3,373,675,000 | 10 |
| government-contracting-related offenses | $1,109,688,435 | 19 |
| safety-related offenses | $104,014,255 | 11 |
| competition-related offenses | $63,466,568 | 6 |
| environment-related offenses | $4,571,885 | 19 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
|---|---|---|
| off-label or unapproved promotion of medical products | $3,373,675,000 | 10 |
| False Claims Act and related | $1,109,688,435 | 19 |
| drug or medical equipment safety violation | $103,840,000 | 5 |
| Foreign Corrupt Practices Act | $60,216,568 | 3 |
| environmental violation | $4,571,885 | 19 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links:
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency |
Penalty Amount |
|---|---|---|---|---|
| Pfizer Inc. | environmental violation | 2012 | CA-DPR | $6,720 |
| HOSPIRA | workplace safety or health violation | 2006 | OSHA | $6,750 |
| PFIZER, INC. | workplace safety or health violation | 2009 | OSHA | $7,155 |
| KING PHARMACEUTICALS | workplace safety or health violation | 2001 | OSHA | $7,200 |
| PFIZER, INC. | workplace safety or health violation | 2012 | OSHA | $9,600 |
| Pfizer Inc. | railroad safety violation | 2002 | FRA | $11,250 |
| Pfizer Pharmaceuticals Ltd. | environmental violation | 2004 | EPA | $20,025 |
| PFIZER INC / GROTON SITE | environmental violation | 2005 | EPA | $22,500 |
| Pfizer Pharmaceuticals | environmental violation | 2010 | EPA | $24,650 |
| WYETH PHARMACEUTICALS COMPANY - OTC | environmental violation | 2000 | EPA | $25,000 |
| Pfizer, Inc. | environmental violation | 2010 | CT-ENV | $31,266 |
| Wyeth Ayerst Pharmaceuticals | environmental violation | 2004 | EPA | $37,000 |
| Wyeth Biopharma | wage and hour violation | 2005 | WHD | $40,187 |
| Pfizer Inc. | environmental violation | 2006 | CT-ENV | $40,224 |
| Wyeth Rouses Point | environmental violation | 2008 | EPA | $44,500 |
| Pfizer Pharmaceuticals LLC | environmental violation | 2005 | EPA | $55,000 |
| Wyeth Pharmaceuticals Company, Inc. | environmental violation | 2010 | EPA | $77,000 |
| SEARLE LTD | environmental violation | 2002 | EPA | $95,000 |
| HOSPIRA, INC. | workplace safety or health violation | 2004 | OSHA | $132,300 |
| Pfizer Pharmaceuticals, LLC | environmental violation | 2016 | EPA | $190,000 |
| Pfizer Inc. | off-label or unapproved promotion of medical products | 2013 | MA-AG | $375,000 |
| Hospira Inc. | employment discrimination | 2015 | OFCCP | $400,000 |
| Alpharma USPD, Inc. | False Claims Act and related | 2010 | ID-AG | $600,000 |
| Purepac Pharmaceutical Co. | False Claims Act and related | 2010 | ID-AG | $600,000 |
| Pfizer Inc. | consumer protection violation | 2018 | NY-AG | $700,000 |
| Pfizer Pharmaceuticals LLC | environmental violation | 2014 | EPA | $728,000 |
| Pfizer Pharmaceuticals, LLC | environmental violation | 2014 | EPA | (*) $728,000 |
| Alpharma, Inc. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Pfizer Inc. | environmental violation | 2008 | EPA | $975,000 |
| Pfizer | consumer protection violation | 2019 | OR-AG | $975,000 |
| PFIZER GLOBAL MANUFACTURING | environmental violation | 2008 | EPA | (*) $975,000 |
| Pfizer | employment discrimination | 2009 | private lawsuit-federal | $1,365,003 |
| Wyeth | benefit plan administrator violation | 2013 | private lawsuit-federal | $2,000,000 |
| Alpharma USPD, Inc., | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
| Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
| King Pharmaceuticals LLC | environmental violation | 2013 | EPA | $2,200,000 |
| KING PHARMACEUTICALS | environmental violation | 2013 | EPA | (*) $2,200,000 |
| Alpharma, Inc. | price-fixing or anti-competitive practices | 2004 | FTC | $2,500,000 |
| Pfizer Inc. | False Claims Act and related | 2011 | MULTI-AG | (*) $2,621,154 |
| Pfizer Inc. and Pharmacia Corp. | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
| Pfizer, Inc. | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
| Pfizer | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
| Pfizer, Inc. and Pharmacia Corporation | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
| Alpharma Inc. | False Claims Act and related | 2010 | MULTI-AG | (*) $8,900,000 |
| Pfizer Inc. | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
| Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
| Pfizer Inc. | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
| Pfizer H.C.P. Corporation | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
| Pfizer Inc. | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Wyeth LLC | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
| Pfizer Inc. | False Claims Act and related | 2002 | MULTI-AG | (*) $21,084,700 |
| Pfizer, Inc. | False Claims Act and related | 2018 | DOJ_CIVIL | $23,850,000 |
| Pfizer Inc. | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
| Wyeth-Ayerst Laboratories Division | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
| Pfizer | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
| Pfizer Inc. | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
| Alpharma Inc. | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
| Pfizer Inc. | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $42,900,000 |
| Pfizer Corporation | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
| Pfizer Inc. | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
| Pfizer Inc. | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $60,000,000 |
| King Pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
| King Pharmaceuticals | False Claims Act and related | 2006 | MULTI-AG | (*) $124,000,000 |
| Warner-Lambert | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*) $190,000,000 |
| Wyeth Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*) $257,400,000 |
| Pfizer, Inc. | kickbacks and bribery | 2009 | MULTI-AG | (*) $331,485,170 |
| Wyeth Pharmaceuticals, Inc. | False Claims Act and related | 2016 | MULTI-AG | (*) $371,351,180 |
| Warner-Lambert | off-label or unapproved promotion of medical products | 2004 | FDA | $430,000,000 |
| Wyeth Pharmaceuticals Inc. | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Pfizer Inc. | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
| Pfizer Inc. | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
